Artificial Intelligence | Machine Learning | Machine Perception Aignostics | Precision Diagnostics for Pathology


Enterprise, Healthcare, Pathology, Drug Development, Clinical Research, Clinical Diagnostics Berlin , Germany

Aignostics

Artificial Intelligence | Machine Learning | Machine Perception


Aignostics | Precision Diagnostics for Pathology

Aignostics

Healthcare, Pathology, Drug Development, Clinical Research, Clinical Diagnostics


Berlin , Germany

Our AI models are trained with clinical-grade data from multiple leading German institutes, and are developed side-by-side with experienced pathologists. A patented “Explainable AI” approach allows us to overcome conventional “black box” limitations of end-to-end AI models. A proprietary cell detection and classification approach enables us to dig deep into morphology and immune responses. We are an interdisciplinary team of machine learners, data scientists, pathologists, biologists, software engineers, regulatory experts and business professionals, focused on three areas: Research, Clinical Trails, CDX & Clinical Routine.

We develop novel algorithms for use in pre-clinical and translational research, on our own data. Our focus lies on assessing complex structures and cell types with AI in H&E, IHC and multiplex IF, in combination with clinical, molecular and proteomics data. We build robust IVDR-compliant AI models from multi-lab data, for H&E, IHC and multiplex IF. We work in close collaboration with pathologists from Charité and other leading institutes, as well as regulatory experts, and can deploy with our own platform. We can certify AI models with you as CDx and deploy them via third-party platforms, or our own platform for use in central labs and our partner institutions, incl. Charité Berlin. We are also working on a suite of proprietary complementary diagnostics. Aignostics started in 2018 within the walls of Charité Berlin and the Berlin Institute of Health, based on years of research conducted by the pathology department of Charité, TU Berlin and Fraunhofer HHI. Following initial incubation, we spun-out of Charité and BIH in 2020, and are now focusing on pioneering computational pathology for pharmaceutical research, clinical trials and CDx development.

 

B2B

1 to 25

Series A

$19.7M

Scaling Up

2019

 
 

Healthcare
Biotechnology

Assessing Complex Structures
Pioneering Computational Pathology

Increase Efficiency

 
 

Analytics
Service

Yes

Active

 
 

   Machine Learning
   Machine Perception


Precision Health Platform

Precision Health Platform

Precision Diagnostic Portfolio

Precision Diagnostic Portfolio


Image

Image

Text

Text

Time Series

Time Series

Semi-Structured

Semi-Structured

Structured

Structured

 

   Software


Python

Python

C/C++

C/C++

Tensorflow

Tensorflow

Kubernetes

Kubernetes

Node.js

Node.js

Typescript

Typescript

JavaScript

JavaScript

MySQL

MySQL

Azure

Azure


Machine Learning Algorithm

Machine Learning Algorithm

Deep Learning Algorithm

Deep Learning Algorithm

Computer Vision Algorithm

Computer Vision Algorithm

 
 

View All

View All AI/ML Jobs

Data Engineer

Berlin, Berlin

Infrastructure Engineer

Berlin, Berlin

Cloud/Platform Engineer

Berlin, Berlin

Backend Software Engineer

Berlin, Berlin

(SENIOR) FRONTEND DEVELOPER

Berlin, Berlin

 

AI/ML Professionals

Want to work at Aignostics?

We can introduce you to the right person at Aignostics

Talk to our Talent Team

 

4

1

$14M

Company was founded 2019 and it took almost 3 years (Sep 2022) to raise first external round

 
 

Date

Round

$ Raised

Investors

09/15/2022

Series A

$14M

Wellington Partners, Boehringer Ingelheim Venture Fund, IBB Ventures, High-Tech Gründerfonds

Date : 09/15/2022

Round: Series A

$ Raised: $14M

Investors: Wellington Partners, Boehringer Ingelheim Venture Fund, IBB Ventures, High-Tech Gründerfonds

 

Investors

Interested in researching Aignostics?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Aignostics

Request a Demo - Deal Souring Platform

 
Viktor Matyas


Viktor Matyas
Co-Founder & CEO

Maximilian Alber


Maximilian Alber
CTO

Jessica Riley

Jessica Riley
Chief Business Officer

Andreas Kunft

Andreas Kunft
Chief Data Officer

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Aignostics